Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Nudo, E. Yoshida, V. Bain, D. Marleau, P. Wong, P. Marotta, E. Renner, K. Watt, M. Deschênes (2008)Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 22 10
Zong Ji, X. Shen, Danying Zhang, H. Liu, Yi Zhou, M. Guo, Ling Dong (2010)Hepatic epithelioid hemangioendothelioma: A report of six patients
Journal of Digestive Diseases, 11
Yoshimichi Komatsu, T. Koizumi, M. Yasuo, Kazuhisa Urushihata, Hiroshi Yamamoto, M. Hanaoka, K. Kubo, S. Kawakami, T. Honda, K. Fujimoto, T. Hachiya (2010)Malignant hepatic epithelioid hemangioendothelioma with rapid progression and fatal outcome.
Internal medicine, 49 12
A. Mehrabi, A. Kashfi, H. Fonouni, P. Schemmer, B. Schmied, P. Hallscheidt, P. Schirmacher, J. Weitz, H. Friess, M. Bũchler, Jan Schmidt (2006)Primary malignant hepatic epithelioid hemangioendothelioma
W. Lau, G. Dewar, A. Li (1989)Spontaneous rupture of hepatic epithelioid haemangio-endothelioma.
The Australian and New Zealand journal of surgery, 59 12
Ying Chen, R. Yu, L. Qiu, D. Jiang, Yan Tan, Yan-Biao Fu (2011)Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma.
World journal of gastroenterology, 17 30
Hsing-Feng Lee, Ching‐Liang Lu, F. Chang (2010)Electronic clinical challenges and images in GI. Multiple hepatic tumors with hemoperitoneum.
Gastroenterology, 138 5
Scott Weiss, Katherine Enzinger (1982)Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma.
Cancer, 50 5
Dr. Madariaga, I. Marino, D. Karavias, M. Nalesnik, H. Doyle, PhD MD, PhD MD, PhD MD (1995)Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma
Annals of Surgical Oncology, 2
K. Ishak, I. Sesterhenn, Major Goodman, L. Rabin, F. Stromeyer (1984)Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases.
Human pathology, 15 9
L. Thin, D. Wong, B. Boer, J. Ferguson, L. Adams, G. MacQuillan, L. Delrivière, A. Mitchell, G. Jeffrey (2010)Hepatic epithelioid haemangioendothelioma: challenges in diagnosis and management
Internal Medicine Journal, 40
C. Raphael, E. Hudson, L. Williams, J. Lester, P. Savage (2010)Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report
Journal of Medical Case Reports, 4
Wu Mengcha (2003)Epithelioid hemangioendothelioma of the liver: a clinicopathological study on 8 cases and review of literature
Chinese Journal of Hepatobiliary Surgery
Jiang Lin, Yuan Ji (2010)CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma.
Hepatobiliary & pancreatic diseases international : HBPD INT, 9 2
张树辉, 丛文铭, 吴孟超 (2003)Epithelioid hemangioendothelioma of the liver: a clinicopathological study on 8 cases and review of literature
H. Makhlouf, K. Ishak, Z. Goodman (1999)Epithelioid hemangioendothelioma of the liver
Min-Shu Hsieh, Po‐Chin Liang, Yu-Chien Kao, C. Shun (2010)Hepatic epithelioid hemangioendothelioma in Taiwan: a clinicopathologic study of six cases in a single institution over a 15-year period.
Journal of the Formosan Medical Association = Taiwan yi zhi, 109 3
T. Grotz, D. Nagorney, J. Donohue, F. Que, M. Kendrick, M. Farnell, S. Harmsen, D. Mulligan, J. Nguyen, C. Rosen, K. Reid-Lombardo (2010)Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option?
HPB : the official journal of the International Hepato Pancreato Biliary Association, 12 8
Shen Ch, Tsai Mh, Cheng Tc, Liu Nj, Sheen Is (1999)Primary hepatic epithelioid hemangioendothelioma: case report.
Changgeng yi xue za zhi, 22 3
Ranjan Mascarenhas, Amit Sanghvi, L. Friedlander, S. Geyer, H. Beasley, D. Thiel (2005)Thalidomide Inhibits the Growth and Progression of Hepatic Epithelioid Hemangioendothelioma
A. Zhao, Li-xin Zhou, Xiang-hong Li (2011)[Hepatic epithelioid hemangioendothelioma in needle biopsy specimens: report of 5 cases with review of literature].
Zhonghua bing li xue za zhi = Chinese journal of pathology, 40 1
J. Lerut, G. Orlando, R. Adam, M. Schiavo, J. Klempnauer, D. Mirza, E. Boleslawski, A. Burroughs, C. Sellés, D. Jaeck, R. Pfitzmann, M. Salizzoni, Gunner Söderdahl, R. Steininger, A. Wettergren, V. Mazzaferro, Y. Treut, V. Karam (2007)The Place of Liver Transplantation in the Treatment of Hepatic Epitheloid Hemangioendothelioma: Report of the European Liver Transplant Registry
Annals of Surgery, 246
F. Salech, S. Valderrama, B. Nervi, J. Rodríguez, D. Oksenberg, A. Koch, G. Smok, I. Duarte, R. Pérez-Ayuso, N. Jarufe, Jorge Martínez, A. Soza, M. Arrese, A. Riquelme (2011)Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up.
Annals of hepatology, 10 1
Yuan Shi, Yingyong Hou (2005)[Hepatic epithelioid hemangioendothelioma: a case report].
Zhonghua bing li xue za zhi = Chinese journal of pathology, 34 6
Longrong Wang, Jiamin Zhou, Yiming Zhao, Hong-wei He, Zongtao Chai, Miao Wang, Yuan Ji, Yi Chen, Chen Liu, Hui-Chuan Sun, Wei-Zhong Wu, Q. Ye, Jian Zhou, Jia Fan, Zhao-You Tang, Lu Wang (2012)Clinical Experience with Primary Hepatic Epithelioid Hemangioendothelioma: Retrospective Study of 33 Patients
World Journal of Surgery, 36
Joel Rodriguez, N. Becker, C. O'Mahony, J. Goss, T. Aloia (2007)Long-Term Outcomes Following Liver Transplantation for Hepatic Hemangioendothelioma: The UNOS Experience from 1987 to 2005
Journal of Gastrointestinal Surgery, 12
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare tumor of vascular origin. Whether HEHE in Chinese patients exhibits similar characteristics compared with Western patients is not well known. The aim of the present study was to summarize the characteristics of HEHE in Chinese patients and identify its prognostic factors. In total, six patients diagnosed with HEHE at the Beijing Friendship Hospital between 2000 and 2012 were combined with 44 previously reported cases in China, retrieved from the literature between 1989 and mid‑2012. These 50 cases from China were compared with 402 patients from Western populations. Prognostic factors were identified by the χ2 test and Cox regression analysis. The male to female ratio of the Chinese patients was 1:2.1 with the mean age of 44.2 years (range, 22‑86 years). The percentage of asymptomatic Chinese patients was significantly higher than in the Western patients (40.0 vs. 24.8%; P=0.026), and that of extrahepatic metastasis (16.0 vs. 36.6%; P=0.005) was significantly lower in Chinese patients. On imaging study, capsular retraction (59.5%) and calcification (26.0%), as well as positivity of CD34 (93.5%) and CD31 (80.6%), were more frequently found in the Chinese patients. Management for the Chinese patients included liver resection (LRx; 45.7%), liver transplantation (LTx; 5.7%), trans‑catheter arterial chemoembolization (14.3%) and palliative treatment (34.3%). Chinese patients with larger‑sized tumor nodules (relative risk (RR), 1.58; 95% confidence interval (CI), 1.032‑2.422; P=0.035) and diffuse type (RR, 12.17; 95% CI, 1.595‑92.979; P=0.016) exhibited unfavorable outcomes. In contrast to Western patients with HEHE, a larger number of Chinese patients were asymptomatic with less extrahepatic metastasis. In China, LRx is widely adopted rather than LTx. Chinese patients with large tumor size or diffuse type may encounter a poorer prognosis.
Oncology Letters – Spandidos Publications
Published: Apr 1, 2014
Access the full text.
Sign up today, get DeepDyve free for 14 days.